139 related articles for article (PubMed ID: 6176449)
21. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
Wagener C; Breuer H
J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
[No Abstract] [Full Text] [Related]
22. Tumor markers: how useful are they?
McIntire KR
Hosp Pract (Off Ed); 1984 Dec; 19(12):55-68. PubMed ID: 6209292
[No Abstract] [Full Text] [Related]
23. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
24. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
25. Detection of malignant ovarian neoplasms: a review of the literature. II. Laboratory detection.
Smith LH; Oi RH
Obstet Gynecol Surv; 1984 Jun; 39(6):329-45. PubMed ID: 6203070
[No Abstract] [Full Text] [Related]
26. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
[No Abstract] [Full Text] [Related]
27. Immunohistochemistry of germ cell and trophoblastic neoplasms.
Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
[TBL] [Abstract][Full Text] [Related]
28. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
29. Tumor markers in testis tumors.
Kansu E
Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
[No Abstract] [Full Text] [Related]
30. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
Harach HR; Skinner M; Gibbs AR
Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and management of cancer using tumor markers].
Torigoe T; Kato H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
[No Abstract] [Full Text] [Related]
32. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
33. [The present status of tumor markers in malignant ovarian tumor].
Nishimura H; Miyoshi T; Hamai J; Miyahara K
Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of oncofetal antigens in patients with ovarian cancer.
Koh SH; Cauchi MN
Aust N Z J Obstet Gynaecol; 1983 May; 23(2):69-72. PubMed ID: 6194783
[TBL] [Abstract][Full Text] [Related]
35. The immune system in gynecologic malignancies.
Barber HR; Dorsett B
Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
[No Abstract] [Full Text] [Related]
36. Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
Calame J; Bosman FT; Schaberg A; Louwerens JW
Int J Gynecol Pathol; 1984; 3(1):92-100. PubMed ID: 6203857
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
38. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
39. Non-seminoma stage III. Current possibilities of "salvage" chemotherapy.
Schmidt CG
Prog Clin Biol Res; 1984; 153():201-18. PubMed ID: 6206506
[No Abstract] [Full Text] [Related]
40. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]